A partial phase out of a top insulin product by Danish drug maker Novo Nordisk may open a bounty for Eris Pharma and its manufacturing partner Biocon Biologics. “It is a small emergency,” says Amit ...

Picture: James Elsby/AFL Photos via Getty Images “The discussion that could be had is, is there available to us a sliding scale? And would that frustration, or would that sentiment be there if ...